Association of Frontal Gray Matter Volume and Cerebral Perfusion in Heroin Addiction: A Multimodal Neuroimaging Study by Niklaus Denier et al.
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PSYCHIATRY
ORIGINAL RESEARCH ARTICLE
published: 21 October 2013
doi: 10.3389/fpsyt.2013.00135
Association of frontal gray matter volume and cerebral
perfusion in heroin addiction: a multimodal
neuroimaging study
Niklaus Denier 1, André Schmidt 1,2, Hana Gerber 1, Otto Schmid 1, Anita Riecher-Rössler 1,
Gerhard A.Wiesbeck 1, Christian G. Huber 1, Undine E. Lang1, Ernst-Wilhelm Radue1,2, MarcWalter 1 and
Stefan Borgwardt 1,2*
1 Department of Psychiatry (UPK), University of Basel, Basel, Switzerland
2 Medical Image Analysis Centre, University Hospital Basel, Basel, Switzerland
Edited by:
Qiyong Gong,West China Hospital of
Sichuan University, China
Reviewed by:
Rex Eugene Jung, University of New
Mexico, USA
Jiansong Xu, Yale University, USA
*Correspondence:
Stefan Borgwardt, Department of
Psychiatry, University of Basel,
Wilhelm Klein-Strasse 27, CH-4012
Basel, Switzerland
e-mail: stefan.borgwardt@upkbs.ch
Structure and function are closely related in the healthy human brain. In patients with
chronic heroin exposure, brain imaging studies have identified long-lasting changes in
gray matter (GM) volume. More recently, we showed that acute application of heroin in
dependent patients results in hypoperfusion of fronto-temporal areas compared with the
placebo condition. However, the relationship between structural and cerebral blood flow
(CBF) changes in heroin addiction has not yet been investigated. Moreover, it is not known
whether there is any interaction between the chronic structural changes and the short
and long-term effects on perfusion caused by heroin. Using a double-blind, within-subject
design, heroin or placebo (saline) was administered to 14 heroin-dependent patients from
a stable heroin-assisted treatment program, in order to observe acute short-term effects.
Arterial spin labeling (ASL) was used to calculate perfusion quantification maps in both
treatment conditions, while Voxel-Based Morphometry (VBM) was conducted to calculate
regional GM density. VBM and ASL data were used to calculate homologous correlation
fields by Biological Parametric Mapping (BPM) and a whole-brain Pearson r correlation. We
correlated each perfusion condition (heroin and placebo) separately with a VBM sample
that was identical for the two treatment conditions. It was assumed that heroin-associated
perfusion is manifested in short-term effects, while placebo-associated perfusion is more
related to long-term effects. In order to restrict our analyses to fronto-temporal regions,
we used an explicit mask for our analyses. Correlation analyses revealed a significant pos-
itive correlation in frontal areas between GM and both perfusion conditions (heroin and
placebo). Heroin-associated perfusion was also negatively correlated with GM in the infe-
rior temporal gyrus on both hemispheres.These findings indicate that, in heroin-dependent
patients, low GM volume is positively associated with low perfusion within frontal regions.
Keywords: heroin addiction, biological parametric mapping, arterial spin labeling, voxel-based morphometry
INTRODUCTION
Heroin dependence is associated with chronic exposure to heroin
and is characterized by compulsive drug use despite negative con-
sequences, including social drift (downward social mobility) (1).
Cognitive processes, including impulse control (control of wishes
and urges), are impaired after acute and chronic heroin exposure,
as indicated by behavioral studies (2). Impaired impulse con-
trol in heroin addiction is reflected by imaging activity patterns
that resemble those of immature brains (3, 4). These function-
ally abnormal activities with impulsive decision-making may be
related to a relapse of heroin addiction. The compulsion to use
heroin is frequently driven by enhanced stress responses and
craving (desire for consumption) (5, 6), while acute heroin admin-
istration contributes to a reduction in these negative emotions, as
indicated by reduced anxiety, craving, and stress hormone release
(7–9). When heroin is administered, it crosses the blood brain bar-
rier very rapidly in comparison to other opioids (10). Within the
brain, the heroin metabolites 6-monoacetylmorphine (6-MAM)
and morphine bind as agonists to µ and κ receptors (11). Both
receptor types are found over the whole-brain (12, 13).
Structural magnetic resonance imaging (MRI) studies on the
long-term effect of opioid application have demonstrated that opi-
oid dependent subjects showed decreased gray matter (GM) in the
bilateral prefrontal cortex and bilateral temporal cortex, includ-
ing the insula (14). Furthermore, Yuan et al. (15) found that the
GM of prefrontal, temporal, and insular regions was negatively
correlated with the duration of heroin use, suggesting that heroin
consumption has a cumulative effect.
Studies on cerebral blood flow (CBF) in heroin addiction have
showed that chronic heroin use is associated with a decrease in
global perfusion, with the greatest decrease in the frontal, occipi-
tal, and temporal regions (16). In our recently published study, we
observed acute effects of heroin on cerebral perfusion (17). Our
findings indicate that, in comparison to placebo, heroin leads to
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hypoperfusion in the left anterior cingulate cortex (ACC), the left
medial prefrontal cortex (mPFC), and in bilateral insula.
However, the relationship between GM volume and perfusion
in heroin addiction has not yet been investigated. In the current
study, we examined whether there was an association between GM
volume and perfusion in 15 heroin-addicted patients. Perfusion
was assessed during the normal drug free condition (placebo) and
after administration of heroin. We applied Biological Paramet-
ric Mapping (BPM) to assess the relation between perfusion – as
measured by arterial spin labeling (ASL) – and GM volume –
as measured by Voxel-Based Morphometry (VBM). The BPM
toolbox was developed by Casanova and colleagues in MAT-
LAB (18). This incorporates information obtained from other
modalities as regressors for whole-brain analyses and also allows
voxel-wise multimodal correlation. BPM has been used widely
for integrative analysis of different neuroimaging modalities
(19–21). On the basis of our previous findings (17), we expected
a direct relationship between perfusion and GM within the areas
with the most marked hypoperfusion during the acute effects of
heroin. We hypothesized that, within the medial frontal and the
temporal cortex, low perfusion should correlates with low GM
volume.
MATERIALS AND METHODS
STUDY SAMPLE
The study was approved by the local ethics committee and reg-
istered under http://clinicaltrials.gov (ID NCT01174927). After
receiving a written and oral description of the study aims, all
participants gave their written informed consent before inclusion.
Fourteen (eight male, six female; mean age 40.7± 6.8 years)
non-left-handed heroin-dependent out-patients were recruited
from the Center of Substance Use Disorders of the Department
of Psychiatry in Basel University. The inclusion criteria were as
follows: age older than 18 years, current heroin-maintained treat-
ment for at least 6 months, with an unchanged heroin dose during
the past 3 months. The exclusion criteria were a positive alco-
hol breathalyzer test, or an additional physical disease or psy-
chiatric disorder other than substance dependencies. Clinically
experienced psychiatrists conducted the Structured Clinical Inter-
view for DSM-IV Axis II Disorders (SCID-II) (22) to assess the
diagnosis of comorbid personality disorders.
Subjects reported their age of first heroin use (mean= 18.4±
2.9 years), years of heroin dependence (mean= 21.4± 7.2 years),
duration of heroin maintenance (mean= 7.2± 3.9 years), and
daily heroin dose (mean= 352± 178 mg). Patients were told to
abstain from illicit drug use other than the prescribed heroin for
the duration of the study, from alcohol intake for 72 h and from
tobacco consumption for 2 h before scanning. Illicit substances
and medications were controlled by a urine test at each session.
Nevertheless, three patients were tested positive for cannabis and
six patients for cocaine at one or both points of the measurement.
DRUG ADMINISTRATION
In a cross-over, double-blind design, placebo (5 ml saline), and
half of the daily heroin dose (mean= 176± 89.1 mg) were admin-
istered intravenously over a period of 30 s by a study nurse 20 min
before the scanning session started. Heroin was dissolved in 5 ml
of sterile water and aspirated into a syringe, according to the pro-
cedure described by Stohler et al. (23). Each patient was scanned
twice, with a short interval between scans (mean 8.4± 3.3 days).
On 1 day, patients received an injection of heroin or placebo
(saline) before the scan and on the other day after the scan. Patients
received their regular morning dose of heroin, corresponding to
half of their daily individual dose.
IMAGE ACQUISITION
Scanning was performed on a 3T MRI scanner (Magnetom Verio,
Siemens Healthcare, Germany), using a 3D T1-weighted sequence
(MPRAGE) for high resolution anatomical data and an ASL
sequence (24) for quantification of CBF (perfusion). MPRAGE
parameters were 1 mm× 1 mm× 1 mm isotropic resolution, rep-
etition time of 2000 ms, inversion time of 1000 ms, and echo
time of 3.4 ms. ASL was based on a flow-sensitive alternating
inversion recovery spin labeling scheme (25), combined with mod-
ified Q2TIPS (TI periodic saturation) pulse preparation and a
single-shot 3D gradient-spin echo readout (26). The sequence
parameters were: repetition time 3200 ms, echo time 12.7 ms,
and spatial resolution 4.6 mm× 4.6 mm× 4 mm (interpolated to
2.3 mm× 2.3 mm× 4 mm). Further details of ASL acquisition
have been described elsewhere (17).
PREPROCESSING OF PERFUSION DATA
Cerebral blood flow (perfusion maps) was calculated by in-house
software from ASL DICOM data. The difference images of the label
and control images were first calculated and the time course was
fitted to an ideal flow model. The equation for perfusion was then
solved (24). The resulting perfusion maps were expressed in the
unit ml/100 g/min. Conversion from the Metafile (MHD) to the
NIFTI format was performed with MedINRIA Software1. Further
preprocessing was conducted by Statistical Parametric Mapping
(SPM82), running under the MATLAB environment. Perfusion
maps were first realigned and then masked with binarized intracra-
nial tissue (binarization threshold: voxel intensity>0.1) to remove
the extracerebral signal. Perfusion maps were then normalized
to MNI space and smoothed using a 6 mm full-width-at half-
maximum (FWHM) Gaussian kernel and proportionally scaled.
More details of perfusion map preprocessing have been described
elsewhere (17).
Voxel-Based Morphometry Structural data (MPRAGE) were
preprocessed with VBM implemented in SPM8. MPRAGE images
were non-rigidly normalized to a population-based average using
diffeomorphic anatomical registration through exponentiated lie
algebra (DARTEL) (27). The segmented tissue maps of GM were
modulated with the Jacobian determinants from the spatial nor-
malization to correct for volume changes. Finally, images were
smoothed with an 8 mm FWHM Gaussian kernel.
Between condition differences were assessed by a voxel-wise
whole-brain analysis using a general linear model (GLM). Statisti-
cal significance was assessed at cluster-level, using non-stationary
random field theory (28). The first step of this cluster-level
inference strategy consisted of identifying spatially contiguous
1http://www-sop.inria.fr/asclepios/software/MedINRIA/
2http://www.fil.ion.ucl.ac.uk/spm/
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FIGURE 1 | BPM analysis pipeline of correlation analyses.
Table 1 | Correlation between gray matter with placebo-associated perfusion.
Area Hemisphere MNI coordinates of
clustermaxima (x,y, z)
Cluster-size
(voxels)
Cluster p-value
(FWE corrected)
Pearson r
POSITIVE CORRELATION
Precentral gyrus R 60, 16, 40 544 <0.001 0.91
Inferior frontal gyrus R 40, 16, 24 0.83
Middle frontal gyrus R 58, 26, 36 0.81
Precentral gyrus R 30, −22, 54 268 <0.001 0.93
Precentral gyrus R 26, −16, 50 0.83
Precentral gyrus R 42, −14, 62 0.78
Superior frontal gyrus R 16, 22, 46 116 0.043 0.88
White matter R 22, 22, 32 0.74
Paracingulate Gyrus/ACC R 10, 14, 48 0.71
Precentral gyrus L −34, 10, 22 428 <0.001 0.91
Inferior frontal gyrus L −50, 8, 12 0.85
Middle frontal gyrus L −32, 24, 28 0.76
Middle frontal gyrus L −40, 20, 56 171 0.004 0.88
Middle frontal gyrus L −40, 6, 44 0.75
Middle frontal gyrus L −48, 22, 46 0.80
Frontal pole L −42, 54, 18 155 0.007 0.83
Frontal pole L −38, 52, 26 0.73
Frontal pole L −36, 46, 38 0.72
Precentral gyrus R 22, −26, 74 121 0.034 0.80
NEGATIVE CORRELATION
No significant clusters
L, left; R, right.
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voxels at a threshold of p< 0.01, without correction (cluster-
forming threshold) (29). Finally, a family-wise error (FWE)
corrected cluster-extent threshold of p< 0.05 was defined in
order to infer statistical significance. A paired t test was used
to examine the following contrasts: GMheroin <GMplacebo and
GMheroin >GMplacebo.
BIOLOGICAL PARAMETRIC MAPPING
For an integrative analysis of multimodal imaging data, we used
BPM3 (18) running with SPM5 software. Preprocessed perfusion
and VBM maps were realigned and used for whole-brain voxel-
to-voxel correlation analysis. In order to restrict our analyses
to fronto-temporal regions, that we had found to be hypoper-
fused during heroin (17), we used an explicit mask of the frontal
and temporal lobe by WFU PickAtlas4. For overview, we refer to
Figure 1.
In BPM, each perfusion condition (heroin and placebo) was
correlated separately with the VBM data. Cluster-level infer-
ence was performed using a homologous correlation field (30)
and a cluster-forming threshold of p< 0.01. Significant clusters
were corrected for multiple comparisons with a FWE of p< 0.05
(29). MNI coordinates of significant clusters were converted into
Talairach space and labeled with the Talairach Client 2.4.35.
In addition, we calculated Pearson r correlations between per-
fusion and VBM data for each voxel within the standardized MNI
space. We used the image calculation function implemented in
SPM8 and applied the Pearson formula r = Σ14i (xi−x¯)(yi−y¯)√
Σ14i (xi−x¯)·Σ14i yi−y¯
to our preprocessed images, where x i and y i represent perfusion
and VBM values, and x¯ and y¯ the mean perfusion and mean VBM
values over the patient’s group, respectively (n= 14).
RESULTS
VOXEL-BASED MORPHOMETRY ANALYSES
Comparison of the heroin and placebo conditions found no
significant difference in either direction (heroin> placebo and
heroin< placebo).
MULTIMODAL CORRELATION ANALYSES
Biological Parametric Mapping analysis integrating GM and per-
fusion data after the placebo treatment revealed a significant
positive correlation between perfusion and GM volume in frontal
areas on both hemispheres including the precentral gyrus, the infe-
rior, middle and superior frontal gyrus, the frontal pole, and the
right paracingulate cortex, including parts of the ACC (Table 1
and Figure 2, upper panel). Pearson r values within the cluster
maxima were all r > 0.7. No significant cluster was found in the
temporal lobe and there was no significant negative correlation
between modalities (Table 1).
Biological Parametric Mapping analysis integrating GM and
perfusion data after the heroin treatment also showed a positive
correlation between perfusion and GM volume in frontal areas.
Significant clusters were found in the left precentral gyrus, the left
3http://www.nitrc.org/projects/rbpm/
4http://fmri.wfubmc.edu/software/pickatlas
5http://www.talairach.org/client.html
FIGURE 2 | Correlation between gray matter volume and perfusion
(axial slices).
middle and inferior frontal gyrus and the frontal pole on both
hemispheres (Table 2 and Figure 2, middle panel). No significant
cluster was found in the temporal lobe. Pearson r values within the
cluster maxima were all r > 0.7. A negative correlation was found
in the inferior temporal gyrus and the temporal fusiform cortex
on both hemispheres (Table 2 and Figure 2, lower panel). Pearson
r values within the cluster maxima were all less than−0.7.
DISCUSSION
In the present study, we examined the relationship between
measurements of two different neuroimaging modalities in
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Table 2 | Correlation between gray matter with heroin-associated perfusion.
Area Hemisphere MNI coordinates of
clustermaxima (x,y, z)
Cluster-size
(voxels)
Cluster p-value
(FWE corrected)
Pearson r
POSITIVE CORRELATION
Precentral gyrus R 60, 16, 40 166 0.008 0.92
Middle frontal gyrus R 58, 26, 38 0.91
Middle frontal gyrus R 52, 16, 50 0.80
Middle frontal gyrus R 40, 40, 42 164 0.009 0.89
Inferior frontal gyrus R 58, 36, −6 223 0.001 0.88
Frontal pole R 50, 56, 2 0.86
Frontal pole R 46, 56, −6 0.80
Inferior frontal gyrus R 32, 14, 24 237 0.001 0.83
Middle frontal gyrus R 40, 18, 32 0.80
Precentral gyrus R 48, 6, 14 0.73
Frontal pole L −18, 58, 30 367 <0.001 0.83
Frontal pole L −40, 50, 26 0.81
Frontal pole L −50, 46, 6 0.78
NEGATIVE CORRELATION
Inferior temporal gyrus R 46 −8 −38 123 0.048 −0.80
Temporal fusiform cortex R 40 −16 −36 −0.79
Inferior temporal gyrus L −46 −16 −34 149 0.016 −0.82
Temporal fusiform cortex L −38 −14 −32 −0.74
L, left; R, right.
heroin-dependent patients, in particular between GM volumes
and perfusion. We compared perfusion maps during acute heroin
treatment and during placebo treatment with GM volumes by per-
forming BPM correlations. We found that both placebo and heroin
perfusion correlated positively with GM in frontal brain regions.
Perfusion during placebo treatment, which we assumed to be
related to the long-term effects of heroin, was also positively asso-
ciated with GM in the cortical midline structure (ACC). We also
found that heroin-associated perfusion correlated negatively with
GM in the inferior temporal gyrus on both hemispheres. This neg-
ative correlation is difficult to explain in terms of our hypothesis
that hypoperfusion is the driving force leading to GM reduc-
tion. The cuneus serves as visual processing and inhibitory control
centers and electroencephalographic studies have revealed abnor-
malities in heroin-dependent individuals (31, 32) and decreased
regional homogeneity (33) in this region. In our VBM analysis we
found, as expected, no significant difference between heroin and
placebo condition.
The regions showing a positive correlation between perfusion
and GM are in line with regions showing reduced GM in heroin
dependence (14, 15, 34, 35). Single photon emission computed
tomography studies have also shown decreased perfusion in frontal
and temporal cortex in opioid dependent patients (16, 36–38).
The frontal cortex is known to play an essential role in heroin
addiction. In a recent study, we could show that heroin impairs
stimulus-driven attention allocation, as indicated by reduced
activity in the right inferior frontal gyrus (39). Further studies
showed that loss of control over drug intake is not only a result
of disrupted subcortical reward circuits but also of prefrontal
higher-order executive functions (40). A recent study showed that
prefrontal impairments in heroin addiction are directly associ-
ated with increases in impulsivity and the duration of heroin
dependence (41). Studies with resting-state functional MRI in
heroin addicts showed a decreased amplitude of low-frequency
fluctuations in fronto-temporal regions (42), reduced regional
homogeneity in the bilateral medial orbitofrontal cortex (33), and
decreased functional connectivity in right dorsal ACC (43). More-
over, graph theoretical analysis demonstrated abnormal topolog-
ical properties in areas of drug addiction-related circuits (44).
Heroin addicts also showed altered default mode and rostral ACC
network properties (45).
However, the question of how perfusion and GM interact in
heroin dependence was not answered in our analysis. A pos-
sible explanation could be that heroin-associated perfusion in
prefrontal and extended limbic areas may alter cerebral volume
due to mild but chronic hypoxia and ischemia. This hypothesis
is in line with animal models of brain ischemia, which showed
that reduction in perfusion leads to neural death and cognitive
impairment (46, 47). It is known that a heroin overdose can
lead to coma with depressed respiration and increased pulse rate
(48). These comas could cause a variety of neurological complica-
tions, including post-anoxic encephalopathy and cerebrovascular
infarctions (49, 50). Interestingly, a study showed that GM dif-
ferences between heroin addicts and a control group diminish
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after only 1 month heroin abstinence (51). This also supports
the idea that GM deficits are caused by heroin itself and are not
pre-existing before heroin addiction. The hypothesis that hypop-
erfusion leads to GM volume reduction by metabolic impairment,
affecting neural, and glial function, is also in line with studies
showing impaired white matter integrity in long-term addiction
(52, 53). White matter microstructure deficits in heroin users
are also associated with the duration of heroin dependence and
impaired decision-making (54).
There are some limitations to this study, which should be care-
fully considered in interpreting our findings. Firstly, we only used
a moderate number of subjects. A second limitation is the lack
of a control group. It was thus not possible to analyze regional
GM and perfusion differences with a between group approach
and it therefore remains unclear how placebo-associated perfu-
sion, reflecting normal perfusion in heroin-dependent patients,
differs from that in healthy controls. A further difficulty is the
aim of separating pure heroin effects on perfusion and structure
from effects of other substances. Abstinence from tobacco use
may induce craving, resulting in increased perfusion in areas
associated with cigarette craving (55). However, all patients were
smokers and therefore nicotine may be ruled out as confound-
ing factor. In our previous analysis, we concluded that cocaine
and cannabis did not significantly modify perfusion in our patient
group (17).
In conclusion, we demonstrated that local GM volumes at base-
line in heroin-dependent patients predicted perfusion in frontal
regions after administration of placebo and heroin. These findings
may suggest that recurrent and chronic hypoperfusion induced by
heroin is a driving force for reduced GM in heroin addiction.
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